Biomarin hopes to have a European approval of its potential new drug for the treatment of severe hemophilia A before summer 2022, the company reports in a press release in connection with its third quarter results.
Biomarin Chair and Chief Executive Jean-Jacques Bienaimé also promises to present data from the company's ongoing phase III trial with Valoctocogene Roxaparvovec in the beginning of 2022.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Hearing firms urge FDA to increase OTC safety requirements
A number of the world’s biggest hearing aid manufacturers have come together to encourage the US health authority to tighten the safety requirements for OTC hearing aids, which will hit the shelves in the US sometime this year.
Coloplast initiates trial of ostomy leakage product
The medtech company will being clinically testing its ostomy add-on product, Heylo, in January.
Top news from MedWatch this week
Miss anything?
Danish bank cuts Genmab price target, retains "buy" recommendation
Jyske Bank has adjusted its valuation of Genmab’s share price target to DKK 2850 (USD 434.4). Investors should continue to buy, the Danish bank says.
Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
Senior Scientist 
Senior Quality Assurance Consultant, Denmark 
QA Specialist 
Medical Director, Translational Medicine 
Compound Development Team Lead 
Chemists are wanted for ALK's internal Aircraft Corps 
Director Medical Science 
Senior HR Director, HR Denmark, Ferring 
KLIFO is looking for a Director, Business Support for our Glostrup office 
GxP QA Compliance Manager for Quality Assurance 
Senior Manager/Associate Director Regulatory Affairs 
Senior Key Account Manager 
Health Economist 
Commercial Excellence Lead 
QA Manager GMP/GDP Compliance & Audits